Eddy diffusivities of inertial particles in random Gaussian flows

We investigate the large-scale transport of inertial particles. We derive explicit analytic expressions for the eddy diffusivities for generic Stokes times. These latter expressions are exact for any shear flow while they correspond to the leading contribution either in the deviation from the shear flow geometry or in the Peclet number of general random Gaussian velocity fields. Our explicit expressions allow us to investigate the role of inertia for such a class of flows and to make exact links with the analogous transport problem for tracer particles.Peer reviewe

Generalization of Taylor's formula to particles of arbitrary inertia

One of the cornerstones of turbulent dispersion is the celebrated Taylor's formula. This formula expresses the rate of transport (i.e., the eddy diffusivity) of a tracer as a time integral of the fluid velocity autocorrelation function evaluated along the fluid particle trajectories. Here, we review the hypotheses which permit us to extend Taylor's formula to particles of any inertia. The hypotheses are independent of the details of the inertial particle model. We also show by explicit calculation that the hypotheses encompass cases when memory terms such as Basset's and Faxén's corrections are taken into account in the modeling of inertial particle dynamics.One of the cornerstones of turbulent dispersion is the celebrated Taylor's formula. This formula expresses the rate of transport (i.e., the eddy diffusivity) of a tracer as a time integral of the fluid velocity autocorrelation function evaluated along the fluid particle trajectories. Here, we review the hypotheses which permit us to extend Taylor's formula to particles of any inertia. The hypotheses are independent of the details of the inertial particle model. We also show by explicit calculation that the hypotheses encompass cases when memory terms such as Basset's and Faxén's corrections are taken into account in the modeling of inertial particle dynamics.One of the cornerstones of turbulent dispersion is the celebrated Taylor's formula. This formula expresses the rate of transport (i.e., the eddy diffusivity) of a tracer as a time integral of the fluid velocity autocorrelation function evaluated along the fluid particle trajectories. Here, we review the hypotheses which permit us to extend Taylor's formula to particles of any inertia. The hypotheses are independent of the details of the inertial particle model. We also show by explicit calculation that the hypotheses encompass cases when memory terms such as Basset's and Faxén's corrections are taken into account in the modeling of inertial particle dynamics.Peer reviewe

Study of Realistic Urban Boundary Layer Turbulence with High-Resolution Large-Eddy Simulation

This study examines the statistical predictability of local wind conditions in a real urban environment under realistic atmospheric boundary layer conditions by means of Large-Eddy Simulation (LES). The computational domain features a highly detailed description of a densely built coastal downtown area, which includes vegetation. A multi-scale nested LES modelling approach is utilized to achieve a setup where a fully developed boundary layer flow, which is also allowed to form and evolve very large-scale turbulent motions, becomes incident with the urban surface. Under these nonideal conditions, the local scale predictability and result sensitivity to central modelling choices are scrutinized via comparative techniques. Joint time–frequency analysis with wavelets is exploited to aid targeted filtering of the problematic large-scale motions, while concepts of information entropy and divergence are exploited to perform a deep probing comparison of local urban canopy turbulence signals. The study demonstrates the utility of wavelet analysis and information theory in urban turbulence research while emphasizing the importance of grid resolution when local scale predictability, particularly close to the pedestrian level, is sought. In densely built urban environments, the level of detail of vegetation drag modelling description is deemed most significant in the immediate vicinity of the trees

In silico screening of nanoporous materials for urea removal in hemodialysis applications

The design of miniaturized hemodialysis devices, such as wearable artificial kidneys, requires regeneration of the dialysate stream to remove uremic toxins from water. Adsorption has the potential to capture such molecules, but conventional adsorbents have low urea/water selectivity. In this work, we performed a comprehensive computational study of 560 porous crystalline adsorbents comprising mainly covalent organic frameworks (COFs), as well as some siliceous zeolites, metal organic frameworks (MOFs) and graphitic materials. An initial screening using Widom insertion method assessed the excess chemical potential at infinite dilution for water and urea at 310 K, providing information on the strength and selectivity of urea adsorption. From such analysis it was observed that urea adsorption and urea/water selectivity increased strongly with fluorine content in COFs, while other compositional or structural parameters did not correlate with material performance. Two COFs, namely COF-F6 and Tf-DHzDPr were explored further through Molecular Dynamics simulations. The results agree with those of the Widom method and allow to identify the urea binding sites, the contribution of electrostatic and van der Waals interactions, and the position of preferential urea–urea and urea–framework interactions. This study paves the way for a well-informed experimental campaign and accelerates the development of novel sorbents for urea removal, ultimately advancing on the path to achieve wearable artificial kidneys

Modeling Parkinson’s disease neuropathology and symptoms by intranigral inoculation of preformed human α-synuclein oligomers

The accumulation of aggregated α-synuclein (αSyn) is a hallmark of Parkinson’s disease (PD). Current evidence indicates that small soluble αSyn oligomers (αSynOs) are the most toxic species among the forms of αSyn aggregates, and that size and topological structural properties are crucial factors for αSynOs-mediated toxicity, involving the interaction with either neurons or glial cells. We previously characterized a human αSynO (H-αSynO) with specific structural properties promoting toxicity against neuronal membranes. Here, we tested the neurotoxic potential of these H-αSynOs in vivo, in relation to the neuropathological and symptomatic features of PD. The H-αSynOs were unilaterally infused into the rat substantia nigra pars compacta (SNpc). Phosphorylated αSyn (p129-αSyn), reactive microglia, and cytokine levels were measured at progressive time points. Additionally, a phagocytosis assay in vitro was performed after microglia pre-exposure to αsynOs. Dopaminergic loss, motor, and cognitive performances were assessed. H-αSynOs triggered p129-αSyn deposition in SNpc neurons and microglia and spread to the striatum. Early and persistent neuroinflammatory responses were induced in the SNpc. In vitro, H-αSynOs inhibited the phagocytic function of microglia. H-αsynOs-infused rats displayed early mitochondrial loss and abnormalities in SNpc neurons, followed by a gradual nigrostriatal dopaminergic loss, associated with motor and cognitive impairment. The intracerebral inoculation of structurally characterized H-αSynOs provides a model of progressive PD neuropathology in rats, which will be helpful for testing neuroprotective therapies

Modeling Parkinson's Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers.

The accumulation of aggregated α-synuclein (αSyn) is a hallmark of Parkinson's disease (PD). Current evidence indicates that small soluble αSyn oligomers (αSynOs) are the most toxic species among the forms of αSyn aggregates, and that size and topological structural properties are crucial factors for αSynOs-mediated toxicity, involving the interaction with either neurons or glial cells. We previously characterized a human αSynO (H-αSynO) with specific structural properties promoting toxicity against neuronal membranes. Here, we tested the neurotoxic potential of these H-αSynOs in vivo, in relation to the neuropathological and symptomatic features of PD. The H-αSynOs were unilaterally infused into the rat substantia nigra pars compacta (SNpc). Phosphorylated αSyn (p129-αSyn), reactive microglia, and cytokine levels were measured at progressive time points. Additionally, a phagocytosis assay in vitro was performed after microglia pre-exposure to αsynOs. Dopaminergic loss, motor, and cognitive performances were assessed. H-αSynOs triggered p129-αSyn deposition in SNpc neurons and microglia and spread to the striatum. Early and persistent neuroinflammatory responses were induced in the SNpc. In vitro, H-αSynOs inhibited the phagocytic function of microglia. H-αsynOs-infused rats displayed early mitochondrial loss and abnormalities in SNpc neurons, followed by a gradual nigrostriatal dopaminergic loss, associated with motor and cognitive impairment. The intracerebral inoculation of structurally characterized H-αSynOs provides a model of progressive PD neuropathology in rats, which will be helpful for testing neuroprotective therapies

Two subsets of stem-like CD8+ memory T cell progenitors with distinct fate commitments in humans

T cell memory relies on the generation of antigen-specific progenitors with stem-like properties. However, the identity of these progenitors has remained unclear, precluding a full understanding of the differentiation trajectories that underpin the heterogeneity of antigen-experienced T cells. We used a systematic approach guided by single-cell RNA-sequencing data to map the organizational structure of the human CD8+ memory T cell pool under physiological conditions. We identified two previously unrecognized subsets of clonally, epigenetically, functionally, phenotypically and transcriptionally distinct stem-like CD8+ memory T cells. Progenitors lacking the inhibitory receptors programmed death-1 (PD-1) and T cell immunoreceptor with Ig and ITIM domains (TIGIT) were committed to a functional lineage, whereas progenitors expressing PD-1 and TIGIT were committed to a dysfunctional, exhausted-like lineage. Collectively, these data reveal the existence of parallel differentiation programs in the human CD8+ memory T cell pool, with potentially broad implications for the development of immunotherapies and vaccines

Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study

OBJECTIVE: To assess the efficacy of recombinant human erythropoietin (rhEPO) in amyotrophic lateral sclerosis (ALS). METHODS: Patients with probable laboratory-supported, probable or definite ALS were enrolled by 25 Italian centres and randomly assigned (1:1) to receive intravenous rhEPO 40,000 IU or placebo fortnightly as add-on treatment to riluzole 100 mg daily for 12 months. The primary composite outcome was survival, tracheotomy or >23 h non-invasive ventilation (NIV). Secondary outcomes were ALSFRS-R, slow vital capacity (sVC) and quality of life (ALSAQ-40) decline. Tolerability was evaluated analysing adverse events (AEs) causing withdrawal. The randomisation sequence was computer-generated by blocks, stratified by centre, disease severity (ALSFRS-R cut-off score of 33) and onset (spinal or bulbar). The main outcome analysis was performed in all randomised patients and by intention-to-treat for the entire population and patients stratified by severity and onset. The study is registered, EudraCT 2009-016066-91. RESULTS: We randomly assigned 208 patients, of whom 5 (1 rhEPO and 4 placebo) withdrew consent and 3 (placebo) became ineligible (retinal thrombosis, respiratory insufficiency, SOD1 mutation) before receiving treatment; 103 receiving rhEPO and 97 placebo were eligible for analysis. At 12 months, the annualised rate of death (rhEPO 0.11, 95% CI 0.06 to 0.20; placebo: 0.08, CI 0.04 to 0.17), tracheotomy or >23 h NIV (rhEPO 0.16, CI 0.10 to 0.27; placebo 0.18, CI 0.11 to 0.30) did not differ between groups, also after stratification by onset and ALSFRS-R at baseline. Withdrawal due to AE was 16.5% in rhEPO and 8.3% in placebo. No differences were found for secondary outcomes. CONCLUSIONS: RhEPO 40,000 IU fortnightly did not change the course of ALS

Modelling human choices: MADeM and decision‑making

Research supported by FAPESP 2015/50122-0 and DFG-GRTK 1740/2. RP and AR are also part of the Research, Innovation and Dissemination Center for Neuromathematics FAPESP grant (2013/07699-0). RP is supported by a FAPESP scholarship (2013/25667-8). ACR is partially supported by a CNPq fellowship (grant 306251/2014-0)